Corpovael SAB (Mexico) Performance
| CADUA Stock | MXN 3.00 0.13 4.15% |
The firm shows a Beta (market volatility) of -0.49, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Corpovael SAB are expected to decrease at a much lower rate. During the bear market, Corpovael SAB is likely to outperform the market. At this point, Corpovael SAB de has a negative expected return of -0.26%. Please make sure to confirm Corpovael SAB's kurtosis, and the relationship between the maximum drawdown and rate of daily change , to decide if Corpovael SAB de performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Corpovael SAB de has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's primary indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
| Begin Period Cash Flow | 579.7 M | |
| Total Cashflows From Investing Activities | -45.2 M |
Corpovael |
Corpovael SAB Relative Risk vs. Return Landscape
If you would invest 355.00 in Corpovael SAB de on November 3, 2024 and sell it today you would lose (55.00) from holding Corpovael SAB de or give up 15.49% of portfolio value over 90 days. Corpovael SAB de is generating negative expected returns and assumes 1.6201% volatility on return distribution over the 90 days horizon. Simply put, 14% of stocks are less volatile than Corpovael, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Corpovael SAB Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Corpovael SAB's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Corpovael SAB de, and traders can use it to determine the average amount a Corpovael SAB's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1621
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CADUA |
Estimated Market Risk
| 1.62 actual daily | 14 86% of assets are more volatile |
Expected Return
| -0.26 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.16 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Corpovael SAB is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Corpovael SAB by adding Corpovael SAB to a well-diversified portfolio.
Corpovael SAB Fundamentals Growth
Corpovael Stock prices reflect investors' perceptions of the future prospects and financial health of Corpovael SAB, and Corpovael SAB fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Corpovael Stock performance.
| Return On Equity | -0.0388 | |||
| Return On Asset | -0.0045 | |||
| Profit Margin | (0.07) % | |||
| Operating Margin | (0.03) % | |||
| Current Valuation | 3.75 B | |||
| Shares Outstanding | 319.17 M | |||
| Price To Book | 0.17 X | |||
| Price To Sales | 0.28 X | |||
| Revenue | 2.78 B | |||
| EBITDA | 125.72 M | |||
| Total Debt | 1.97 B | |||
| Book Value Per Share | 14.87 X | |||
| Cash Flow From Operations | 283.75 M | |||
| Earnings Per Share | 0.55 X | |||
| Total Asset | 10.13 B | |||
About Corpovael SAB Performance
By examining Corpovael SAB's fundamental ratios, stakeholders can obtain critical insights into Corpovael SAB's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Corpovael SAB is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Things to note about Corpovael SAB de performance evaluation
Checking the ongoing alerts about Corpovael SAB for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Corpovael SAB de help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Corpovael SAB de generated a negative expected return over the last 90 days | |
| Corpovael SAB de has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 2.78 B. Net Loss for the year was (103.64 M) with profit before overhead, payroll, taxes, and interest of 684.78 M. | |
| About 68.0% of the company shares are held by company insiders |
- Analyzing Corpovael SAB's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Corpovael SAB's stock is overvalued or undervalued compared to its peers.
- Examining Corpovael SAB's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Corpovael SAB's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Corpovael SAB's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Corpovael SAB's stock. These opinions can provide insight into Corpovael SAB's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Corpovael Stock
Corpovael SAB financial ratios help investors to determine whether Corpovael Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Corpovael with respect to the benefits of owning Corpovael SAB security.